Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Reem Shalabi"'
Autor:
Georg Aue, Robert Reger, Phuong Vo, Richard W. Childs, Tatyana Worthy, Sharon Adams, Willy A. Flegel, Brian Wells, Emily C. McDuffee, Xin Tian, Kamille A. West, Reem Shalabi, Enkhtsetseg Purev, Geri Hawks, Lisa Cook
Publikováno v:
Br J Haematol
Heavily transfused patients frequently develop human leukocyte antigen (HLA) allo-immunization resulting in platelet transfusion refractoriness and a high risk for life-threatening thrombocytopenia. Data suggest complement activation leading to the d
Autor:
Robert Reger, David F. Stroncek, Joseph A. Clara, Patricia Prince, Jennifer S. Wilder, Josef Rivero, Richard W. Childs, Rosa Nadal Rios, Lisa Cook, Brian Wells, Kate Stringaris, Xin Tian, Willy A. Flegel, Mohamed Samour, Kristen Gunn, Reem Shalabi, Georg Aue
Publikováno v:
Blood. 136:37-38
Introduction Severe Aplastic Anemia (SAA) is a life-threatening bone marrow failure disorder associated with pancytopenia, serious infections, and transfusion dependence. Although long term survival for SAA patients (pts) can be achieved with immunos
Autor:
Catalina Ramos, Elena Cho, David F. Stroncek, Robert Reger, Richard W. Childs, Hanh Khuu, Reem Shalabi, Neal S. Young, Georg Aue, Enkhtsetseg Purev, Tatyana Worthy, Phuong Vo, Lisa Cook, Jeremy Pantin, Xin Tian
Publikováno v:
British Journal of Haematology. 176:950-960
Allogeneic haematopoietic stem cell transplantation is curative for severe aplastic anaemia (SAA) unresponsive to immunosuppressive therapy. To reduce chronic graft-versus-host disease (GVHD), which occurs more frequently after peripheral blood stem
Autor:
Tatyana Worthy, Richard W. Childs, Reem Shalabi, Emily C. McDuffee, Lisa Cook, C Ramos-Delgado, George Aue, Phuong Vo
Publikováno v:
Bone Marrow Transplant
Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic hematopoietic stem cell transplantation
Autor:
Richard W. Childs, Brian Wells, Michelle A Borg, Reem Shalabi, Georg Aue, Thomas E. Hughes, Lisa Cook, Tracey Walsh-Chocolaad, Kristen Gunn, Tatyana Worthy, Xin Tian, Rodica Ciurea
Publikováno v:
Blood. 134:2012-2012
Background: Recipient immunity is compromised after HSCT, obligating patients (pts) to take prophylactic antimicrobial and antiviral agents and to be reimmunized to viral and bacterial pathogens. Hepatitis B virus (HBV) infection is a major public he
Autor:
Tatyana Worthy, Sharon Adams, Patricia Prince, Reem Shalabi, Robert Reger, Jennifer Wilder, Richard W. Childs, Xin Tian, Phuong Vo, Geri Hawks, David F. Stroncek, Kristen Gunn, Brian Wells, Lisa Cook, Willy A. Flegel, Joseph A. Clara, Georg Aue
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S210-S211
Introduction Allogeneic hematopoietic stem cell transplantation using UCB (UCBT) is an alternative approach for severe aplastic anemia (SAA) patients (pts) lacking an HLA matched donor. However, UCBT is associated with delayed engraftment, high graft
Autor:
David F. Stroncek, Jennifer S. Wilder, Xin Tian, Tatyana Worthy, Robert Reger, Richard W. Childs, Willy A. Flegel, Brian Wells, Patricia Prince, Lisa Cook, Kristen Gunn, Sharon Adams, Phuong Vo, Georg Aue, Reem Shalabi, Joseph A. Clara
Publikováno v:
Blood. 132:5789-5789
Introduction. Allogeneic hematopoietic stem cell transplantation using UCB is an alternative approach for pts (pts) with hematological malignancies lacking an HLA matched donor. However, for pts with severe aplastic anemia (SAA), UCB transplants are
Publikováno v:
JAMA Dermatol
Autor:
Enkhtsetseg, Purev, Xin, Tian, Georg, Aue, Jeremy, Pantin, Phuong, Vo, Reem, Shalabi, Robert N, Reger, Lisa, Cook, Catalina, Ramos, Elena, Cho, Tat'yana, Worthy, Hanh, Khuu, David, Stroncek, Neal S, Young, Richard W, Childs
Publikováno v:
Br J Haematol
Allogeneic haematopoietic stem cell transplantation is curative for severe aplastic anaemia (SAA) unresponsive to immunosuppressive therapy. To reduce chronic graft-versus-host disease (GVHD), which occurs more frequently after peripheral blood stem
Autor:
Nancy L. Geller, Thomas J. Walsh, Teresa Donohue, Sakti Chakrabarti, C. Carvallo, Ramaprasad Srinivasan, Richard W. Childs, David E. Kleiner, Takehito Igarashi, Reem Shalabi, Yoshiyuki Takahashi, Austin John Barrett
Publikováno v:
British Journal of Haematology. 124:777-786
Approximately 15% of patients undergoing non-myeloablative allogeneic haematopoietical cell transplantation (NMHCT) develop steroid-refractory acute-graft versus host disease (aGVHD), a usually fatal complication. We encountered 18 cases of steroid-r